Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
Three Healthcare Distribution Industry Trends To Watch
For nearly a century, the HDA Factbook has reported on the productivity behind the safe and effective delivery of millions of medicines and healthcare products nationwide. Published by the HDA Research Foundation, the latest Factbook reveals that approximately 95 percent of all pharmaceutical sales moved through the traditional distribution segment in 2023, among other key findings. A recent LinkedIn Live discussion provided additional perspective into the trends shaping the pharmaceutical distribution industry amid an evolving business environment.
HDA Honors Rx and Consumer Product Manufacturers With DIANA Awards
The Healthcare Distribution Alliance (HDA) honored 10 pharmaceutical and consumer product manufacturers with Distribution Industry Awards for Notable Achievements in Healthcare (DIANA Awards) at the 2025 HDA Business and Leadership Conference in Orlando, Fla.
HDA Statement on “Most-Favored-Nation” Executive Order
HDA released a statement in response to President Donald J. Trump’s Executive Order establishing a “Most-Favored-Nation” (MFN) pricing policy for pharmaceuticals.
HDA Announces Government Affairs and Policy Staffing Updates
The Healthcare Distribution Alliance (HDA) announces updates regarding staff leading its Government Affairs and Policy teams.
HDA Statement on Drug Shortages
Healthcare Distribution Alliance (HDA) President and CEO Chip Davis released the following statement in response to the Senate Finance Committee hearing entitled, “Drug Shortages: Examining Supply Challenges, Impacts, and Policy Solutions from a Federal Health Program Perspective.”